SLC47A1 and type 2 diabetes mellitus: Compared with carriers of the AG genotype, normal weight T2DM patients with the SLC47A1 rs2289669 AA or GG genotype had a better effect in lowering FINS and HOMA-IR after a two-month metformin monotherapy.